(Informal 1-2 line summaries, which certainly should not be relied upon for legal or other research purposes)
-
- In this precedential claim construction and 102(b)(2)(B) decision, CAFC affirms the presumption that "the same terms appearing
in different portions of the claims should be given the same
meaning unless it is clear from the specification and prosecution history that the terms have different meanings at
different portions of the claims" - here, the appearances of the term "internal diameter" in claims for "a tool used in the oil and gas industry to assist with inserting a long strip of pipe (the “casing” or “casing string”) to the bottom of a wellbore."
CAFC first confirms that the challenge hasn't been waived:
"Nine neither changed its position on this issue between the trial and appellate levels nor forfeited its
argument that “internal diameter” is a measured diameter . . . the intrinsic evidence does not
clearly require “internal diameter” to have two different
meanings . . . Because the intrinsic record was not clear that “internal diameter” should carry different meanings in
different portions of the claims of the ’445 patent, the district court erred by holding that the term “can refer to both
an inner surface and a measured diameter” . . . Instead, we conclude that the plain meaning of “internal diameter” is a “measured diameter” across the width of the
casing string."
CAFC then similarly agrees that "the district court erred by construing “casing string” to mean “pipe that is customarily
≥ 4.5 inches in outer diameter, which is intended to line the
walls of a drilled well so that a downhole tool can be deployed without restriction”" and that the challenge is similarly preserved:
"Nine proposes the same
construction here as it did to the district court . . . Because the issue was
fully litigated at the district court, Nine has preserved its
challenge to the district court’s construction on appeal . . . On the merits, nothing in the intrinsic record requires
a size limitation on casing string . . . NCS argues that the extrinsic evidence demonstrates
that persons of ordinary skill in the art would understand
“casing string” to have a size of ≥ 4.5 inches in diameter,
“because wellbores that are lined with casing string have a
standard size, and tubing tools for completing well operations have to fit inside of the casing string so they can be
run downhole” . . . NCS primarily relies on industry
catalogs . . . The problem with NCS’s position is that, even if those
catalogs were evidence of definitional plain meaning rather
than mere commonality, any such definition is explicitly
contradicted by the specification."
Next, CAFC addresses a public use challenge, and usefully, and perhaps most importantly, clarifies the bounds o the Sanho decision:
"[In Sanho] Prior to the filing date, the inventor
testified that he “sent to Sanho via private courier a finished version of the [HyperDrive]” and alleged a prior public disclosure . . . Although there was no confidentiality or nondisclosure agreement, there was no teaching of the features of
the invention to others beyond Sanho . . . On
these facts, we [did] not think it [was] a close question . . . . [T]he sale of the HyperDrive here did not publicly disclose the subject matter[.]" . . . In Sanho, we did “not decide exactly what is necessary for demonstrating
that a sale publicly disclosed the relevant subject matter,
or whether to apply the prevailing standard for when a
printed publication is sufficiently publicly accessible to
qualify as prior art.”
Finally, in accordance with the recent Sanho decision, CAFC overturns the jury, since the prior commercial sale was insufficiently "public" to set aside prior art under 102(b)(2)(B):
"As in Sanho, there is no evidence that
AirLocks were widely distributed or placed where the public could examine them. Instead, NCS’s CEO testified that,
even when sold to Tundra, the AirLock was delivered in a
sealed black tube that would have to be cut open . . . NCS has not identified any record evidence that, for example, the public would be able to understand from the black tube that there was a “rupture disc [ ]
configured to disengage from sealing engagement when exposed to a pressure greater than a hydraulic pressure in
the casing string after the casing string has been positioned in the wellbore and the region of the tubular member where the rupture disc is attached has a larger internal
diameter than the internal diameter of the casing string” . . . Thus, as in Sanho, while there
was no non-disclosure agreement, there was no teaching."
Ergo, after addressing various other miscellaneous issues, CAFC vacates and remands.
-
- Another precedential decision in the murky realm of exclusive rights / patent standing.
Basically, defendant alleges that the exclusive licensee plaintiff lacks adequate rights, since the owner wasn't joined and plaintiff ceased "business operations" sufficient to maintain its license. CAFC disagrees.
"A&M granted TexasLDPC an exclusive license to the asserted patents and copyrights in exchange
for equity in TexasLDPC, a percentage of sublicense royalties, and a percentage of any money recovered from enforcing the asserted patents and copyrights . . . A&M maintains the option to terminate the Agreement if TexasLDPC “fails to exert commercially reasonable efforts to
achieve any milestone” by the established deadline . . . if TexasLDPC
failed to record net sales or sublicensing revenue by 2021,
A&M also had the option to terminate the Agreement “unless [TexasLDPC] is exercising commercially reasonable efforts to enforce Copyrights or Patent Rights or seek
collections . . . Though TexasLDPC undisputedly met the milestones
outlined in § 5.01,3 by summer 2019, TexasLDPC exhausted its capital and had been unable to secure any customers or sublicensees . . . Defendants alleged that TexasLDPC’s pivot to enforcement . . . triggered the Agreement’s immediate termination under
§ 8.03(a)(iii), because TexasLDPC “cease[d] its business operations” . . . After a hearing on Defendants’ 12(b)(1) argument, TexasLDPC filed a supplemental agreement
(nunc pro tunc agreement) between itself and A&M, asserting the contract term “business operations” always included enforcement. Id. TexasLDPC claimed this nunc pro
tunc agreement had retroactive effect and thus cured any
jurisdictional defect . . . the district court ultimately determined that TexasLDPC
lost its legal interest in the case when it shifted its business
to enforcement, because the contract language and extrinsic evidence demonstrated that the contract ended automatically . . . Further, the district court deemed the
nunc pro tunc agreement ineffectual.”
Oddly, however, the DCT further considered A&M a necessary party, finding that:
"[T]he Agreement conveyed “incomplete rights” because: (i) it
barred suit against Marvell [a preexisting nonexclusive licensee]; (ii) it reserved to A&M the exclusive right to enforce the Marvell license; and (iii) it reserved to A&M the right to develop the patented
technology." (my clarification)
CAFC first sets aside the conclusion that plaintiff ceased operations by the language of the license: "The Agreement explicitly includes enforcement under
its definition of “commercially reasonable efforts” . . . The Agreement also grants TexasLDPC its right to use,
sublicense, and sue under the patents without elevating
one right above the others . . . ogether, these provisions demonstrate that the
Agreement unambiguously contemplates enforcement as
one of TexasLDPC’s business operations . . . The district court accorded the Agreement’s recitals too
much weight and settled on an overly narrow view of “business operations.”"
Turning to substantial rights, CAFC agrees with plaintiff that it had sufficient rights:
"While the “all substantial rights” inquiry in this case is
a close call, the rights-grant in this case is most comparable
to Luminara . . . TexasLDPC’s right to sue is essentially unfettered, thereby protecting Defendants from the possibility
of facing multiple lawsuits on the same patents. A&M retains the right to participate in certain lawsuits, but
A&M’s participation is limited by consent from Texas’s Attorney General, and A&M can only initiate litigation
against Marvell . . . The district court determined the Agreement did not
grant “all substantial rights” because A&M retained the
right to practice the patents and the sole ability to enforce
the Marvell license. This was error. In accordance with Luminara, A&M’s retained right to practice the asserted patents is not a “substantial right requiring joinder,” because the threat of the
patents’ invalidation does not endanger that right . . . While A&M retains the sole right to bring suit against
Marvell, this retained right as to just a single previous licensee has limited effect on TexasLDPC’s substantial patent rights"
Finally, as to necessary parties under FRCP 19(a), CAFC concludes as "suggested in Luminara, that A&M
is not a necessary party to this litigation under Rule
19(a)(1)(B) for the same reasons we used to determine TexasLDPC possesses all substantial rights to the patents-insuit." Importantly, CAFC notes that a "separate inquiry regarding
whether an absent party is necessary under Rule
19(a)(1)(A) may be required where the question of according “complete relief” is not factually tied to the rights-grant
from patent owner to licensee."
"TexasLDPC insists that the district court’s reliance on the
inability to obtain certain discovery information from A&M
was in error, because it is unrelated to whether the parties
can be accorded proper relief . . . Defendants and the district court both suggest that TexasLDPC’s reliance upon a
damages theory consisting of a reasonable royalty based on
a hypothetical negotiation—assessed using the GeorgiaPacific factors—has made evidence controlled by A&M essential to the district court’s damages calculation . . . Rule 19 is not a discovery tool . . . We agree that Rule 19 “does not list the
need to obtain evidence from an entity or individual as a
factor bearing upon whether or not a party is necessary or
indispensable to a just adjudication” . . . even if we agreed with Defendants that additional licensing information held exclusively by A&M is relevant to other Geogia-Pacific factors, Defendants conceded
that A&M already produced the only two A&M licenses directly related to the asserted patents . . . The mere fact that A&M may possess certain information does not turn an absent party into one that is necessary under Rule 19(a)."
(I expect subpoenas are the more proper vehicle rather than joinder in these situations, but I'm not a litigator).
In any event, in view of the above, CAFC reverses.
-
- CAFC precedentially affirms noninfringement based upon construction of the term "universal" for various spinal-fusion implant claims. Here, Appellant:
"[A]rgues that the district court erred in its (1) conclusion that the preambles of
claims 1 and 10 (which depends from claim 1) of the
’913 patent and claim 47 of the ’022 patent are limiting and
(2) construction of the term “universal.” "
Regarding 1), CAFC agrees with the DCT that . . .
"[t]he preamble at issue furnishes essential meaning to
the claim. The claim does not merely recite a gripper with
a plurality of prongs and a screw guide. It recites one that
is, as the district court explained, “capable of manipulating
and inserting ‘a universal, intervertebral bone fusion
spacer’ into a disc space” . . . The “Background of the Invention” section describes “[t]he present invention” as
relating “to a unique universal bidirectional screw (BDS) system” (emphasis CAFC's) . . . We conclude
that because the drafter “cho[se] to use both the preamble
and the body to define the subject matter of the claimed
invention, the invention so defined, and not some other, is the one the patent protects.” (emphasis in original)."
Similarly, CAFC agrees with the analysis around 2):
"“[U]niversal[ity]” is a fundamental characteristic of the claimed invention and thus, even if considered alone, we would
conclude that it is limiting . . . Moskowitz argues that the district court’s construction
incorrectly requires “a hypothetical one-size-fits-all intervertebral bone fusion spacer/bi-directional transvertebral
screw fusion device to be suitable for implantation in every
region of the spine for every patient” . . . We see no error in the district court’s construction. The
district court pointed to the patents’ specifications, which
provide for multiple uses in all three spinal regions . . . the patents unambiguously describe the device as being adaptable across spinal
regions and usable with multiple surgical approaches.
That adaptability makes the design “universal.”"
Ergo, CAFC affirms en toto.
-
- In this precedential trade secrets damages matter CAFC reverses and affirms in part. Regarding the former, CAFC interestingly confirms that trade secret damages may be based upon unjust enrichment regardless of licensing history:
"Versata argues that under
both the Defend Trade Secrets Act and Michigan Uniform
Trade Secrets Act, it is allowed to pursue unjust enrichment damages as a matter of statutory right. We agree
with Versata that it was entitled to pursue unjust enrichment damages; the district court legally erred when it precluded Versata from doing so . . . We . . . conclude that Versata may seek unjust enrichment damages under the DTSA and the MUTSA
as a matter of law . . . The district court’s reliance in this case on precedent
where the parties’ licensing history was used to calculate
damages to categorically preclude recovery of unjust enrichment damages is misplaced."
CAFC similarly reverses as to breach of contract damages, reviving the jury award:
"Versata argues that the district court erred in reducing
the jury award because it presented sufficient evidence for
the jury to accurately calculate damages. We agree and
conclude that the district court erred when it reduced the
jury award from $82,260,000 to $3. Accordingly, we reverse
the district court’s JMOL Decision and reinstate the jury
award for breach of contract damages"
As for the affirmance, CAFC agrees with the DCT that the specific combination of elements in the trade secret need not be identified:
"Ford argues that “Versata offered insufficient evidence that Ford had knowledge of each alleged combination trade secret.” . . . That is, Ford
claims that Versata provided no evidence that it identified the specific “bundles of features [Grid, Buildability, and Workspaces of the ACM software] to Ford” but instead provided hundreds of documents to Ford containing these trade secrets . . Therefore, because Versata failed to demonstrate that Ford had specific knowledge of the ACM combination trade secrets, Ford argues that the district court’s judgment on trade secret liability must be reversed. Neither the DTSA nor the MUTSA,
however, requires a plaintiff to show a defendant’s
knowledge of specific elements of combination trade secrets . . . Nothing
in the language of either statute requires the degree of specific knowledge of the exact combination of a trade secret
that Ford urges us to read in."
Ergo, reversed in part and affirmed in part.
-
- CAFC affirms attorney sanctions under 285 in this optics filters patent infringement matter. Basically, plaintiff understood defendant's filters met standards implying infringement, but only actually analyzed a no longer extant filter product:
"[Defendant] asserted that summary judgment was warranted because Viavi’s infringement contentions identified only the 11246 Filter, which had been released of any pre-May 1, 2020 infringement and that had not been manufactured or
sold since May 1, 2020 . . . [Plaintiff] opposed the summary judgment motion . . . It contended that the scope of the case went beyond the 11246 Filter, even as that was the only filter included in the claim charts accompanying Viavi’s complaint. Further, Viavi contended it was entitled to reasonable discovery from PTOT so that it could obtain information about any of PTOT’s filters that were incorporated
into the major company’s devices."
Here, plaintiff asserts that its pre-suit diligence was sufficient to avoid sanctions, but CAFC agrees with the DCT that the diligence focused on the "wrong" filter and that "a more thorough investigation would have prevented Viavi from
invoking the 11246 Filter in its suit against PTOT".
"In fact,
as soon as Viavi finally purchased several of the major company’s devices, it discovered that the only non-Viavi filter
being used in one of these devices was not the 11246 Filter . . . After learning this, Viavi even
initiated a new action wherein it sued based only on Filter
#25, not on the 11246 Filter. Therefore, Viavi’s own actions
indicate that, with a more searching pre-suit investigation,
it “would have not filed” the suit it ended up filing here."
Ergo, after considering and rejecting other arguments involving the anticipated results of discovery, CAFC affirms.
James Skelley is a solo practitioner based in Mountain View, California since 2015, focusing primarily upon technology transactions and intellectual property procurement. James' practice also serves as an "incubator" for new legal service technologies / methodologies and a "living example" of their application. To this end, James regularly partners with larger law firms and with his clients so as to improve the practice of intellectual property law.
- Utility / Design / PCT Patent Prosecution
- Open Source Diligence
- Technology Transactions (typically as a team)
- Litigation / Inter Partes Review Support (typically as a team)
- James tends NOT to handle low-volume trademark work (though referrals are available)
- USPTO - #59458 - 10/16/2006
- California - #257829 - 12/01/2008
- District Columbia - #1014986 - 08/05/2013
- James is available by email, 8x8 hangout, and in-person meetups in the Valley.
- Email is typically the best way to reach James.
- Machine Learning / Robotics
- Cryptograpy / Cryptocurrency / Smart Contracts
- Medical Device
- Computational Biology (primarily modeling and proteomics)
- Signal Processing (primarily wireless and compression)
- Quantum Physics (primarily semiconductor) / Electromagnetics (antennae, waveguides, etc.)
- Manufacturing / 3D Printing
- James tends NOT to handle pure chemistry applications (though referrals are available), however James HAS handled matters involving computational proteomics, cellular modeling, and diagnostic lab protocols
LawMux Bites are (very) short, one-page summaries of various legal concepts, cases, and technologies. As informal summaries, you certainly shouldn't rely upon them as legal advice / for business use, but they can help orient you if you're new to the subject matter.